U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07894250) titled 'Q-Angle, Segment Length, Quadriceps, and Knee Alignment in Soccer Players' on Oct. 14. Bri... Read More
U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07894367) titled 'Gematinib Combined With Lenvatinib for the Treatment of Locally Advanced or Metastatic Non-... Read More
U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07895940) titled 'Prehospital Care of End-of-Life Patients by the Strasbourg Mobile Emergency and Resuscitati... Read More
U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07894068) titled 'IMB-Guided Health Education Intervention for Medication Adherence and Blood Pressure Contro... Read More
Dhaka, Oct. 27 -- Four construction contracts have been signed for two metro rail projects in Dhaka, covering eight stations and key infrastructure along routes from the airport to Kamalapur and Gabto... Read More
India, Oct. 27 -- Aerospace and defense major Boeing Co. reported Tuesday that its third-quarter net loss narrowed sharply, while it recorded an operating profit, compared to prior year's loss, amid l... Read More
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A longitudinal study to investigate innate immune reprogramming following Herpes Zoster vaccinatio... Read More
U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07894952) titled 'Implementing IVM for Fertility Treatment in Clinical Practice' on Oct. 07. Brief Summary: ... Read More
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'Phase I/II study of Mezigdomide and Elranatamab for relapsed/refractory multiple myeloma patients ... Read More
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'Phase Ib/II Study of Tislelizumab in Combination with Bevacizumab and Capecitabine in Advanced Sol... Read More